Eli Lilly’s Alzheimer’s Drug Kisunl...

By HEOR Staff Writer

September 30, 2024

Introduction Eli Lilly has achieved a milestone with its Alzheimer's drug Kisunla, recently approved by Japan's health ministry. Donanemab (Kisunla) is an antibody drug designe...
Dementia Prevention in Latin America: A Focus on Modifiable Risk Factors
The Impact of Atrial Fibrillation on Quality of Life and Healthcare Costs
Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools
Healthy Ageing through Occupational Therapy for Frail Older Adults
The Effect of Sedentary Behaviour on Healthy Ageing
Falls Prevention in Australia: A Systemic Approach
The Economic Impact of Fall Prevention in Hospitals: Evaluating the Fall TIPS...
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Enhancing Health Outcomes with Geriatric-Specific Cancer Rehabilitation
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
Preventing Falls Among Older Adults: A Vital Healthcare Imperative
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research